TELO: Telomir Pharma Average Forecast Price
Telomir Pharmaceuticals (TELO) is a biopharma startup developing breakthrough molecules to slow aging by targeting telomeres. This chart shows that share prices are currently at 6.03. While the business relies on precision medicine, it faces colossal scientific risks and a struggle for capital. Research stability is maintained through laboratory diversification and strict control over the logistics of chemical components.
Analytical breakdowns for Telomir Pharma (TELO)
- stock quotes and analyst forecast:
- market capitalization information:
- shareholders' equity book value data:
- issuer credit burden and liquidity indicators:
Aggregate Debt to Equity Telomir Pharmaceuticals|TELO - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Telomir Pharmaceuticals Corp|TELO - Company Aggregate Debts|Debts to Book Capitalization Telomir Pharma|TELO - Company Long-Term Debt|Company Short-Term Loans and Borrowings Telomir Pharmaceuticals|Quick Liquidity Indicator telomirpharma.com
- financial results and valuation multiples details:
TELO - Net Profit|Projected Future Earnings Telomir Pharmaceuticals|TELO - Price to Earnings Ratio|Future Price to Earnings Multiple Telomir Pharmaceuticals Inc|TELO - Price/Earnings to Growth Ratio|Company Value to EBITDA Telomir Pharma|TELO - Operating profit before deduction of amortization|Earnings per share for the last four quarters Telomir Pharmaceuticals|TELO - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months telomirpharma.com|TELO - Earnings growth in current year|Expected net earnings per share growth next year Telomir Pharmaceuticals
General company analysis:TELO telomirpharma.com
This indicator captures the arithmetic mean target price of shares based on current forecast revisions, allowing for the identification of emerging fundamental trends and the risk of overheated optimism. By analyzing the weighted average target trend, an investor can assess the recovery phase of Telomir Pharmaceuticals (TELO), where the automation of anti-aging drug synthesis faces time constraints due to lengthy clinical trials.
Competitors of Telomir Pharmaceuticals
Analyst Forecast Prices HLN|Analyst Consensus Forecast KVUE (Kenvue)|Verona Pharma PLC (VRNA) - Average Forecast Price|MENS - Price Target Chart|LGND: Price Target Chart|Amneal Pharmaceuticals (AMRX) - Price Target Chart|Average Forecast Price perrigo.com (PRGO)|Price Target Chart Alvotech SA|Liquidia Corp - Forecast Levels Chart|Analyst Consensus Forecast GLPG|ANIP (ANI Pharmaceuticals Corp) - Fair Value Consensus|Analyst Consensus Forecast MNKD (MannKind Corporation)|Analyst Consensus Forecast amphastar.com AMPH|PCRX - Price Target Chart|Fair Value Consensus SPRY (ARS Pharmaceuticals Inc)|Theravance (TBPH) - Price Target Chart|Consensus Target Aquestive Corp|SCPH (scPharmaceuticals, Inc.) - Analyst Consensus Forecast|Analyst Consensus Forecast Tectonic|Consensus Target TNXP (Tonix Pharmaceuticals Holding Corp.)|SXTC (sxtchina.com) - Fair Value Consensus|Price Target Chart Eupraxia Pharmaceuticals Inc. EPRX|BioHarvest Sciences Inc (BHST) - Average Forecast Price|EXOZ: Consensus Target|Oramed Pharmaceuticals - Analyst Forecast Prices|ENTX: Analyst Consensus Forecast|MindWalk Holdings, Inc. - Fair Value Consensus|ABVC (ABVC BioPharma Inc) - Analyst Consensus Forecast|Average Forecast Price Cumberland Corp CPIX|Price Target Chart Quantum BioPharma Ltd (QNTM)|FGEN (fibrogen.com) - Fair Value Consensus|Rani Therapeutics Holdings, Inc. - Consensus Target|Analyst Forecast Prices SNYR (Synergy CHC Corp.)|Rallybio Corp. - Analyst Consensus Forecast|Average Forecast Price Lexaria Bioscience|Pulmatrix, Inc. (PULM) - Price Target Chart|PTHL (Pheton Holdings) - Price Target Chart|Price Target Chart Aptorum Group Ltd|Average Forecast Price Lyra Therapeutics Inc. LYRA|Price Target Chart Impact BioMedical Inc (IBO)|Consensus Target tnfpharma.com TNFA|Analyst Consensus Forecast YCBD (cbdMD)|Analyst Median Target painreform.com (PRFX)|CYTO - Price Target Chart|Fair Value Consensus LIPO (Lipella Pharmaceuticals Inc)|OPTN (Optinose) - Consensus Target|Pieris Pharma - Fair Value Consensus|Price Target Chart Procaps Group S.A.|petrospharma.com - Forecast Levels Chart|Analyst Consensus Forecast QLI|SLRN (Acelyrin Inc.) - Fair Value Consensus|Analyst Consensus Forecast TFFP (TFF Pharma)
